Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.540
-0.050 (-3.14%)
At close: Dec 5, 2025, 4:00 PM EST
1.610
+0.070 (4.55%)
After-hours: Dec 5, 2025, 7:34 PM EST
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $408.66 million as of December 5, 2025. Its market cap has increased by 4.07% in one year.
Market Cap
408.66M
Enterprise Value
441.23M
1-Year Change
4.07%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $408.66M, a decrease of -16.27%. That is a compound annual growth rate of -1.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 421.90M | 1.79% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 906.03B |
| Johnson & Johnson | 486.77B |
| AbbVie | 399.46B |
| UnitedHealth Group | 298.85B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 248.13B |
| Abbott Laboratories | 218.25B |